FRANKFURT--The following is a summary of analysts' forecasts for Astrazeneca plc (AZN.LN) first-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in pence, according to IFRS). Earnings figures are scheduled to be released April 29.

=== 
                Sales:           Seroquel 
1st Quarter        Total  Nexium       XR Symbicort Crestor 
AVERAGE            5,548     489      234       805   1,085 
Prev. Year         5,748     644      262       845   1,167 
+/- in %            -3.5     -24      -11      -4.8    -7.0 
 
MEDIAN             5,527     473      233       806   1,094 
Maximum            5,775     565      244       859   1,243 
Minimum            5,356     453      225       745     985 
Amount                 7       7        6         6       7 
 
Bernstein          5,775     514      237       859   1,243 
Cowen and Company  5,505     565      225       745     985 
Deutsche Bank      5,613     453      233       791   1,101 
Exane BNP Paribas  5,478     473      244       785   1,094 
Jefferies          5,583     471      232       820   1,131 
Morgan Stanley     5,527     466      233       827     988 
UBS                5,356     484       --        --   1,054 
 
                Core:               Net 
                  Operat.        attrib. 
1st Quarter       profit    PBT  profit     EPS 
AVERAGE            1,635  1,490   1,224    0.97 
Prev. Year         1,805  1,682   1,368    1.08 
+/- in %            -9.4    -11     -11     -10 
 
MEDIAN             1,586  1,454   1,201    0.95 
Maximum            1,812  1,638   1,353    1.07 
Minimum            1,545  1,370   1,137    0.90 
Amount                 7      5       7       7 
 
Bernstein          1,737  1,584   1,298    1.03 
Cowen and Company  1,545  1,370   1,137    0.90 
Deutsche Bank      1,586  1,454   1,201    0.95 
Exane BNP Paribas  1,628     --   1,242    0.98 
Jefferies          1,812  1,638   1,353    1.07 
Morgan Stanley     1,583     --   1,185    0.94 
UBS                1,553  1,405   1,150    0.91 
 
            Target price    Rating                 DPS 2016 
AVERAGE            4,625    positive 4    AVERAGE      2.80 
Prev. Quarter      4,875    neutral  3    Prev. Year   2.80 
+/- in %            -5.1    negative 0    +/- in %       -- 
 
MEDIAN             4,676                  MEDIAN         -- 
Maximum            5,600                  Maximum        -- 
Minimum            3,600                  Minimum        -- 
Amount                 6                  Amount          4 
 
Bernstein          4,352    Market perform               -- 
Cowen and Company  3,600    Market perform             2.80 
Deutsche Bank      5,600    Buy                        2.80 
Exane BNP Paribas  5,000    Outperform                 2.80 
Jefferies          4,200    Hold                         -- 
Morgan Stanley          --  Overweight                   -- 
UBS                5,000    Buy                        2.80 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

(END) Dow Jones Newswires

April 27, 2016 07:00 ET (11:00 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Astrazeneca Charts.